Urogen Pharma Ltd (URGN)

Cost of Revenue

$17.28M

TTM · Period ending: · USD

URGN logo

URGN Cost of Revenue

Latest reported$17.28M
URGN TTM Cost of Revenue ($28.00K → $17.28M)
High-resolution chart · PNG

URGN cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Urogen Pharma Ltd Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
17,278,000
14,256,000
12,447,000
11,629,000
10,804,000
9,483,000
8,881,000
8,696,000
8,610,000
8,824,000
9,361,000
9,338,000
8,991,000
8,394,000
7,654,000
6,980,000
6,204,000
5,785,000
5,157,000
4,220,000
3,285,000
1,906,000
1,009,000
357,000
23,501,000
23,453,000
45,886,000
45,886,000
23,488,000
23,806,000
1,803,000
2,090,000
1,330,000
1,012,000
600,000
341,000
46,000
46,000
28,000
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.